A tricalcium phosphate ceramic material for 3D printing designed for bone substitute implants and surgical applications. It is used as a scaffold material in bone replacement and surgical reconstruction procedures.
Manufactured by
Lithoz
Austria
Lithoz is the world and technology leader for high-performance ceramic and bioresorbable materials and 3D printers. Founded in 2011, Lithoz is committed to breaking the boundaries of ceramic production and supporting customers in expanding the manufacturing opportunities for the ceramic industry. The company's innovative additive manufacturing solutions enable the production of complex ceramic components that were previously impossible to manufacture using traditional methods.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
LEALMEDICAL
Brazil · 1 relevant product
GENOSS CO., Ltd.
South Korea · 4 relevant products
Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd
China · 3 relevant products
32 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 25 relevant matches
LEALMEDICAL · Brazil
Bone substitute material composed of beta-tricalcium phosphate for orthopedic and regenerative medicine applications.
GENOSS CO., Ltd. · South Korea
Advanced synthetic bone graft material for periodontal and implant applications. Provides biocompatible scaffold for bone regeneration.
Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd · China
A three-component composite bone repair scaffold composed of PLGA (polylactic-co-glycolic acid), β-TCP (beta-tricalcium phosphate), and degradable metallic magnesium, manufactured using low-temperature 3D printing technology. The material features macro-micro porous biomimetic structure with pore sizes of 100-900μm and micro-pores ≤50μm, mechanical strength >2.0 MPa approaching cancellous bone, and complete in-vivo degradation within 6-9 months. Clinical trials across eight major hospitals demonstrated 100% bone fusion rate at 24 weeks with no adverse reactions and effective antimicrobial and anti-tumor properties.
22 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products